Penang, 22 June 2026 – UMediC Group Berhad posted stronger revenue for the cumulative nine months ended 30 April 2026, supported by improved contributions from its marketing and distribution business as the medical devices and consumables group advances its next phase of manufacturing-led growth.
For the third quarter under review, UMediC recorded revenue of RM12.4 million, representing a 6.8% increase from RM11.6 million in the corresponding quarter a year earlier. The improvement was mainly driven by stronger performance from the group’s marketing and distribution segment, reflecting sustained demand for medical devices and healthcare-related solutions.
Unlock the Full Article
This article is exclusive to The Ledger Asia Subsribers / PAID members.
Already have an account? Log in here
